FDA Inspection 1170711 — Bergen Community Regional Blood Center
The FDA completed an inspection of Bergen Community Regional Blood Center on May 26, 2022 in Parsippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 26, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Parsippany, NJ (United States)